$4.59
5.03% yesterday
Nasdaq, Aug 12, 10:00 pm CET
ISIN
US81720R1095
Symbol
SNES

SenesTech, Inc. Stock price

$4.59
-0.16 3.37% 1M
+1.46 46.65% 6M
+1.28 38.67% YTD
+0.72 18.60% 1Y
-715.41 99.36% 3Y
-2,131.41 99.79% 5Y
-195,835.41 100.00% 10Y
-195,835.41 100.00% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.22 5.03%
ISIN
US81720R1095
Symbol
SNES
Industry

Key metrics

Basic
Market capitalization
$24.0m
Enterprise Value
$22.6m
Net debt
positive
Cash
$1.7m
Shares outstanding
1.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
12.4 | 3.6
EV/Sales
11.7 | 3.2
EV/FCF
negative
P/B
8.3
Financial Health
Equity Ratio
76.6%
Return on Equity
-246.3%
ROCE
-196.3%
ROIC
-
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$1.9m | $4.3m
EBITDA
$-5.9m | $-4.3m
EBIT
$-6.1m | $-5.6m
Net Income
$-6.0m | $-11.3m
Free Cash Flow
$-5.9m
Growth (TTM | estimate)
Revenue
39.9% | 130.2%
EBITDA
20.2% | 29.0%
EBIT
19.4% | 10.4%
Net Income
19.9% | -83.3%
Free Cash Flow
21.9%
Margin (TTM | estimate)
Gross
61.3%
EBITDA
-308.2% | -101.5%
EBIT
-314.8%
Net
-312.0% | -264.6%
Free Cash Flow
-305.1%
More
EPS
$-4.6
FCF per Share
$-3.3
Short interest
11.5%
Employees
23
Rev per Employee
$80.0k
Show more

Is SenesTech, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

SenesTech, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a SenesTech, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a SenesTech, Inc. forecast:

Buy
86%
Hold
14%

Financial data from SenesTech, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1.93 1.93
40% 40%
100%
- Direct Costs 0.75 0.75
5% 5%
39%
1.18 1.18
103% 103%
61%
- Selling and Administrative Expenses 5.49 5.49
20% 20%
284%
- Research and Development Expense 1.63 1.63
46% 46%
84%
-5.94 -5.94
20% 20%
-308%
- Depreciation and Amortization 0.13 0.13
44% 44%
7%
EBIT (Operating Income) EBIT -6.07 -6.07
19% 19%
-314%
Net Profit -6.01 -6.01
20% 20%
-311%

In millions USD.

Don't miss a Thing! We will send you all news about SenesTech, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

SenesTech, Inc. Stock News

Neutral
Seeking Alpha
5 days ago
SenesTech, Inc. (NASDAQ:SNES ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Joel L. Fruendt - CEO, President & Director Thomas C.
Neutral
The Motley Fool
5 days ago
SenesTech (SNES) Q2 Sales Jump 36%
Neutral
PRNewsWire
5 days ago
94% Revenue Growth in Evolve™ Rodent Birth Control Products Strong Cash Balance and Sustained Progress Toward Profitability SURPRISE, Ariz. , Aug. 7, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the secon...
More SenesTech, Inc. News

Company Profile

SenesTech, Inc. engages in the development and commercialization of a proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. It offers its ContraPest product to residential, and commercial sector such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer in July 2004 and is headquartered in Phoenix, AZ.

Head office United States
CEO Joel Fruendt
Employees 23
Founded 2004
Website senestech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today